Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
or

Geovax Labs (GOVX)

Geovax Labs (GOVX)
0.8400 x 100 0.8700 x 10
Post-market by (Cboe BZX)
0.8500 +0.0300 (+3.66%) 04/23/25 [NASDAQ]
0.8400 x 100 0.8700 x 10
Post-market 0.8700 +0.0200 (+2.35%) 19:12 ET
Quote Overview for Wed, Apr 23rd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.8300
Day High
0.8800
Open 0.8400
Previous Close 0.8200 0.8200
Volume 323,300 323,300
Avg Vol 461,125 461,125
Stochastic %K 18.28% 18.28%
Weighted Alpha -88.73 -88.73
5-Day Change -0.0026 (-0.31%) -0.0026 (-0.31%)
52-Week Range 0.7300 - 11.1800 0.7300 - 11.1800
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,319
  • Shares Outstanding, K 13,839
  • Annual Sales, $ 3,950 K
  • Annual Income, $ -24,990 K
  • EBIT $ -25 M
  • EBITDA $ -25 M
  • 60-Month Beta 3.70
  • Price/Sales 2.66
  • Price/Cash Flow N/A
  • Price/Book 1.59
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -5.67
  • Most Recent Earnings $-0.30 on 03/27/25
  • Next Earnings Date 05/13/25 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.59
  • Number of Estimates 2
  • High Estimate -0.55
  • Low Estimate -0.63
  • Prior Year -2.47
  • Growth Rate Est. (year over year) +76.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7300 +16.16%
on 04/15/25
Period Open: 1.3100
1.4100 -39.86%
on 03/25/25
-0.4620 (-35.27%)
since 03/21/25
3-Month
0.7300 +16.16%
on 04/15/25
Period Open: 2.1400
2.2400 -62.14%
on 01/24/25
-1.2920 (-60.37%)
since 01/23/25
52-Week
0.7300 +16.16%
on 04/15/25
Period Open: 1.5400
11.1800 -92.42%
on 08/19/24
-0.6920 (-44.94%)
since 04/23/24

Most Recent Stories

More News
World Cancer Day Sparks Big Questions About Pollution, Genetics, and Innovation

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – As World Cancer Day (Feb. 4) fades into the rearview, attention is shifting to the latest discussions...

ONCY : 0.5666 (-5.57%)
ZNTL : 1.5000 (+2.04%)
NYT : 50.44 (+0.64%)
ABSI : 3.19 (-0.62%)
GOVX : 0.8480 (+3.68%)
ONC.TO : 0.79 (-5.95%)
GSK : 37.03 (+1.09%)
New Vaccine Technologies Lead the Charge as Global Immunization Efforts Evolve

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – According to the World Health...

PCVX : 33.16 (+6.08%)
BVAXF : 0.0286 (-4.98%)
BIOV.CN : 0.0400 (unch)
GILD : 106.38 (+0.82%)
GOVX : 0.8480 (+3.68%)
ARCT : 12.65 (+3.94%)
GeoVax Labs, Inc. Secures U.S. Patent Notice of Allowance for Tumor Immunotherapy Technology

GeoVax Labs receives patent allowance, enhancing its intellectual property for cancer immunotherapy using its unique viral vector platform.Quiver AI SummaryGeoVax Labs, Inc. announced that the U.S. Patent...

GOVX : 0.8480 (+3.68%)
3 Penny Stocks Ready to Break Out in 2025

Vuzix, GeoVox Labs, and Cardiol Therapeutics emerged as notable penny stocks late in 2024 for their potential to scale operations and launch new products.

VUZI : 1.7100 (+3.01%)
CRDL : 1.0800 (+9.09%)
GOVX : 0.8480 (+3.68%)
GeoVax Labs, Inc. CEO David Dodd to Present at NobleCon20 Conference

GeoVax Labs announces CEO David Dodd will present at NobleCon20 on corporate updates and clinical trials.Quiver AI SummaryGeoVax Labs, Inc., a biotechnology company focused on human vaccines and cancer...

GOVX : 0.8480 (+3.68%)
GeoVax, SIGA Jump After WHO Extends Mpox Public Emergency Status: Here’s What Retail Thinks

Emergent Biosolutions and Chimerix also saw marginal gains after the announcement.

SIGA : 6.24 (+1.79%)
EBS : 4.98 (+5.51%)
GOVX : 0.8480 (+3.68%)
CMRX : 8.54 (-0.12%)
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GOVX),(NYSE:GSK),(NASDAQ:AZN),(NYSE:MRK) EQNX::TICKER_END

ONCY : 0.5666 (-5.57%)
AZN : 68.51 (+0.94%)
MRK : 78.74 (-0.29%)
GOVX : 0.8480 (+3.68%)
ONC.TO : 0.79 (-5.95%)
GSK : 37.03 (+1.09%)
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth

ONCY : 0.5666 (-5.57%)
AZN : 68.51 (+0.94%)
MRK : 78.74 (-0.29%)
GOVX : 0.8480 (+3.68%)
ONC.TO : 0.79 (-5.95%)
GSK : 37.03 (+1.09%)
GeoVax Reports 2022 Second Quarter Financial Results and Provides Corporate Update

Advancing Phase 2 Clinical Trials for COVID-19 and Immuno-Oncology Evaluation of Company’s Vaccine Platform Against Monkeypox Underway ATLANTA, GA,...

GOVXW : 0.0300 (-0.66%)
GOVX : 0.8480 (+3.68%)
GeoVax Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate Against Sudan Ebolavirus Showing 100% Protection With a Single Immunization

ATLANTA, GA, July 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing human vaccines and...

GOVXW : 0.0300 (-0.66%)
GOVX : 0.8480 (+3.68%)

Business Summary

GeoVax Labs Inc. is a clinical-stage biotechnology company. It engages in developing human vaccines against infectious diseases and cancer using a novel patented Modified Vaccinia Ankara-Virus Like Particle based vaccine platform. GeoVax Labs Inc. is based in ATLANTA, GA.

See More

Key Turning Points

3rd Resistance Point 0.9278
2nd Resistance Point 0.9047
1st Resistance Point 0.8763
Last Price 0.8480
1st Support Level 0.8248
2nd Support Level 0.8017
3rd Support Level 0.7733

See More

52-Week High 11.1800
Fibonacci 61.8% 7.1881
Fibonacci 50% 5.9550
Fibonacci 38.2% 4.7219
Last Price 0.8480
52-Week Low 0.7300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective